Sorry MHK, commentary on other stocks doesn't belong here... have a read of the AGM report for PNV and it'll tell you most of what you ask.
As for RHY, with only small numbers of shares available that are really tightly held... it is really hard to predict what SP will be with further announcements eg: study 7 results, CE Mark, TGA approval etc... suffice to say RHY is looking astoundingly positive.
The big question for me... will holders have the guts to hold their shares to make this company a long term Australian blue chip investment or will a big player come along and buy the tech before we gain the income such IP will create??
I'm hoping for the long game and we commercialise this from Australia. GLTAH.
Gav
Ann: Rhythm Biosciences - Investor Presentation, page-15
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.34M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $2.291K | 20.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 23335 | 3 |
View Market Depth
| Last trade - 11.54am 08/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |